CDK4 and Miyoshi myopathy: Furthermore, CDK4/6 inhibitor abemaciclib successfully inhibited oral MM cells’ proliferation, synergistically with dacarbazine, a cytostatic drug commonly used for treating metastatic melanoma (Table 1, Figure 4).